Polycystic kidney (PCK) rats, an animal model of Caroli's disease, show a dilatation of intrahepatic bile ducts (IHBD) called ''ductal plate malformation.'' Mesenchymal cells and the Notch and Hedgehog signaling pathways in portal tracts are reportedly involved in the normal development of IHBD, although there have been no studies on the roles of these signaling pathways in PCK rats. We immunohistochemically examined the expression of the molecules related to these signaling pathways in portal tracts. All molecules related to these signaling pathways expressed in portal tracts in Sprague Dawley (SD) rats (control) were also expressed in PCK rats. Mesenchymal cells (myofibroblasts) were frequently found in the connective tissue of portal tracts of 20 embryonic-day-old (E20D), 1-day-old (1D), and 1-week-old (1W) SD and PCK rats and were abundant in PCK rats. Interestingly, myofibroblasts almost disappeared at in both strains of 3W rats. Jagged1 was expressed in mesenchymal cells in portal tracts and was abundant in PCK rats. Double immunostaining showed that Jagged1-positive cells were myofibroblasts. Notch2 and HES1 were expressed in cholangiocytes of the bile ducts of both rats. Sonic Hedgehog was similarly expressed in the bile ducts of both rats. A well-balanced and time-sequential expression of the Notch and Hedgehog family in portal tracts might be essential for the normal development of IHBD in E20D to 1W SD rats, and an imbalanced interaction of these molecules, particularly increased Jagged1 expression in periductal and periportal myofibroblasts and Notch2 expressed in cholangiocytes, may be involved in the formation of bile duct lesions in PCK rats.
INTRODUCTION
Caroli's disease is characterized by the progressive multiple dilatation of intrahepatic bile ducts (IHBD) with congenital hepatic fibrosis (CHF) [1] . Most cases of Caroli's disease with CHF show an autosomal recessive inheritance and are associated with autosomal recessive polycystic kidney disease (ARPKD) [2] . Polycystic kidney (PCK) rats, an animal model of ARPKD [2, 3] , spontaneously develop cystic changes of renal tubules and show a multifocal and irregular dilation of IHBD known as ''ductal plate malformation'' (DPM) and fibrosis of the portal area [2, 3] . Ductal plate malformation, an abnormal biliary and stromal malformation, is characterized by an irregularly shaped and variably dilated duct lumen covered by a low columnar or cuboidal biliary epithelium, bulging or irregular protrusions covered by biliary epithelium into the dilated lumen, and bridge-like structures covered by biliary epithelium in the dilated lumen [4, 5] . It is characteristically found in patients with Caroli's disease and CHF or in PCK rats [2] [3] [4] [5] . Autosomal recessive polycystic kidney disease develops as a result of mutations in the causal PKHD1 gene. Polycystic kidney rats show a deficiency of the PKDH1 protein product, fibrocystin, in the primary cilia, with malformation of primary cilia, which is believed to cause bile duct lesions [6] . Disordered cell kinetics of biliary epithelial cells, such as MEK5-ERK5 cascade activation, have been reported to contribute to DPM [3, 7] . Basal laminar components and stromal fibrogenesis may also play important roles. Biliary overexpression of plasminogen and tissue-type plasminogen activator leads to the generation of excessive amounts of plasmin, and subsequent plasmin-dependent lysis of the extracellular matrix molecules may contribute to the formation of DPM [8, 9] . Several genetic changes involving hepatocyte nuclear factor (HNF)-6, HNF1b, and cystin were also reported to be involved in the DPM process [8, 10] .
The PCK rat is characterized by progressive hepatic fibrosis [2] . Our previous study revealed 2 types of intrahepatic bile ducts: those lined with cuboidal-shaped (C-type) and flat-shaped (F-type) cholangiocytes [11] . Although the latter was thought to participate in progressive hepatic fibrosis by producing extracellular matrix molecules, the exact mechanisms remain speculative.
Notch signaling is an important pathway in the development of various organs, as well as nerves and blood vessels [12, 13] . In mammals, Notch1 and Notch 2 transduce signals from their ligands, Jagged1 and Jagged2, expressed on neighboring cells. This Notch pathway is also important for the normal development of IHBD [14, 15] , and anomalous biliary development may be directly or indirectly associated with impaired signaling pathways of the Notch family. For example, mutations in Jagged1 cause Alagille syndrome characterized by a paucity of bile ducts [16] [17] [18] . Jagged1 is crucial for the commitment of hepatoblasts to cholangiocytes and essential for the morphogenesis of IHBD, particularly for the control of the 2nd layer of ductal plates during the remodeling of bile ducts [14] . Notch2 signaling pathways also reportedly regulate the differentiation and survival of cholangiocytes and induction of tubulogenesis during the development of IHBD. For example, Tchorz and colleagues [15] reported that expression of the intracellular domain of Notch2 (Notch 2ICD) caused hepatoblasts to differentiate into cholangiocytes, which form additional bile ducts in periportal regions and ectopic ducts in lobular regions, and additional bile ducts in periportal regions are maintained into adulthood, resulting in an increased number of bile ducts per portal tract.
It has been reported that mesenchymal cells in the portal area of mice express Jagged1, and such mesechymal cells are known to express a-smooth muscle actin (a-SMA) [14] . In mice whose expression of Jagged1 in portal mesenchymal cells in the portal area has been selectively knocked out, the formation of the tubular structure of the bile ducts is inhibited [17] . Taken together, a well-balanced expression and signaling pathway of Jagged1 in periductal mesenchymal cells and Notch2 in cholangiocytes of IHBD might be mandatory for the normal development of bile ducts [14] .
So far, there have been many reports on the pathophysiologic roles of Notch family signaling pathways in genetic and acquired biliary diseases, such as Alagille syndrome [16] [17] [18] . For Caroli's disease, however, there have been few studies on the altered signaling pathways of Hedgehog (Hh) responsible for DPM and no studies on Notch family signaling pathways in either the disease itself or its animal model, PCK rats [19, 20] .
In this study, we examined the roles of Notch and Hh signaling pathways mainly by immunostaining molecules related to these pathways in the normal development of IHBD and also the formation of bile duct lesions in PCK rats.
MATERIALS AND METHODS

Animals and collection of liver tissue specimens
Polycystic kidney rats were maintained at the Laboratory Animal Institute of Kanazawa University Graduate School of Medicine in Japan (Sakura FineTek Japan Co, Ltd, Tokyo, Japan). Normal (Crl:CD (Sprague Dawley [SD])) rats used as a control were purchased from Charles River Japan (Sagamihara, Japan). Livers were removed from fetal (18 and 20 embryonic-day-old) (E18D and E20D), and neonatal (1-day-old, 1-week-old, and 3-weekold) (1D, 1W, and 3W) rats. After preliminary experiments, more than 5 SD and PCK rats of each age were killed. Liver samples were immersed in a 10% formalin neutral buffer solution (pH 7.4), embedded in paraffin, or were freshly embedded in OTC compound, and quickly frozen in liquid nitrogen. More than 20 serial sections, 4 mm thick, were cut from the paraffin-embedded and frozen tissues. Several of these sections were stained with hematoxylin and eosin (H&E) and Azan-Mallory, and the remainder were subjected to an immunohistochemical analysis. Parts of the tissue were immediately frozen in liquid nitrogen for use in the reverse transcription polymerase chain reaction (RT-PCR). In this study, IHBDs and bile ductules were mainly examined. Epithelial cells lining bile ductules and bile ducts are known as cholangiocytes. All animal studies were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals at Takara-machi Campus of Kanazawa University, Kanazawa, Japan.
Immunohistochemistry
Immunostaining of Jagged1, Jagged2, Notch1, Notch2, Hes1, a-SMA, Sonic Hedgehog (Shh), Ki-67, and ssDNA was performed using fresh frozen sections or paraffinembedded sections of livers from PCK and SD rats. Primary antibodies and their sources are shown in Table 1 . Frozen sections were fixed with cold acetone followed by blocking of endogenous peroxidase and then incubated with primary antibodies (Jagged1, Jagged2, Notch1, Notch2, and Hes1) for 1-2 hours at room temperature. Paraffin-embedded sections were deparaffinized and after blocking of endogenous peroxidase were incubated with individual primary antibodies (a-SMA, Shh, Ki-67, and ssDNA) for 1-2 hours at room temperature. The sections were then incubated with a secondary antibody conjugated to the peroxidase-labeled polymer (Histofine Simple Stain Rat MAX PO, Nichirei Biosciences Inc., Tokyo, Japan). Color development was performed using 3,3-diaminobenzidine tetrahydrochloride. Jagged1, Jagged2, Notch1, Notch2, a-SMA, and Shh sections were lightly counterstained with hematoxylin. Hes1, Ki-67, and ssDNA sections were not counterstained. The negative control was evaluated by substitution of the primary antibodies with corresponding nonimmunized serum.
Double fluorescence immunostaining
Single-color fluorescence immunostaining of Notch2 and double-color immunostaining of a-SMA and Jagged1, a-SMA and Jagged2, and a-SMA and Notch1 were performed as follows. Fresh frozen sections were fixed with cold acetone. After the blocking of endogenous peroxidase, the sections were incubated overnight at 4uC with antibody for Notch2 or a mixture of antibodies for a-SMA and Jagged1 or a-SMA and Jagged2. The primary antibodies are listed in Table 1 . The detection of Notch2, Jagged1, and Jagged2 was performed using a Tyramide Signal Amplification kit with Alexa Fluor 488 (Invitrogen, Carlsbad, CA, USA). Alpha smooth muscle antigen was detected with Alexa Fluor 594 secondary antibody (Invitrogen). Nuclei were stained with 49, 6-diamidino-2-phenylindole.
Reverse transcription polymerase chain reaction
Total RNA was extracted from cryostat sections of the liver using an RNA extraction kit (RNeasy Mini, Qiagen K. K., Tokyo, Japan) and used to synthesize cDNA with reverse transcriptase (ReverTra Ace, Toyobo Co., Osaka, Japan). Then PCR was performed with KOD DNA polymerase (KOD-Plus or KOD-Plus-Neo, Toyobo Co.) and primer sets for Notch1, Notch2, Jagged1, Jagged2, HES1, Shh, Gli1, and b-actin. The sequences of the primers used for PCR are shown in Table 2 . The PCR products were subjected to 1% agarose gel electrophoresis and stained with ethidium bromide.
Image analysis ImageJ 1.45s (National Institutes of Health, Bethesda, MD, USA) was used to measure a-SMA-positive areas in the liver specimens and for gel densitometry for semiquantitative RT-PCR.
Labeling index (LI) of Ki-67 and ssDNA
Ki-67 expression and ssDNA expression were evaluated in more than 500 cholangiocytes of intrahepatic bile ducts in SD and PCK rats, and the percentage of positive cells was expressed as Ki-67 LI and ssDNA LI. The former reflects proliferative activities and the latter, apoptosis.
Statistics
The mean and standard deviation (SD) were calculated for all parameters. Statistical differences between SD and PCK rats were determined using a Student t-test or Aspin-Welch test, after an analysis of the homogeneity of variance by an F-test. Values of P , 0.05 were considered to be statistically significant. 
RESULTS
Pathology of liver and bile ducts in PCK rats
Polycystic kidney rats showed abnormal biliary and stromal changes (DPM) characterized by an irregularly shaped and variably dilated lumen covered by low columnar or cuboidal cholangiocytes [1] . These DPM patterns were not clearly identifiable in E18D PCK rats but became evident in E20D, 1D, 1W, and 3W PCK rats ( Fig. 1A,B ). Portal tracts were composed of loose connective tissue containing many mesenchymal cells. The loose fibrous stroma was abundant in PCK rats, particularly around the bile ducts and portal veins, compared to SD rats. In 3W SD and PCK rats, such tissue was significantly less abundant and more hypocellular. In 3W PCK rats, IHBD was largely classifiable into 2 types: bile ducts lined with (1) cuboidal/columnar cholangiocytes (C-type) and (2) squamous epithelium similar to mesenchymal cells (F-type) ( Fig. 2A ) [11] .
Distribution of a-SMA-positive mesenchymal cells (myofibroblasts) in the portal tracts Alpha smooth muscle antigen was constantly expressed in the vascular smooth muscle before and after birth in both rats. In E20D, 1D, and 1W SD rats, mesenchymal cells positive for a-SMA (myofibroblasts) were found in the enlarged portal tracts (Fig. 1C and Fig. 3A ). In 3W rats, there were almost no myofibroblasts in the portal tracts. Myofibroblasts were found in the enlarged portal tracts of E20D, 1D, and 1W PCK as seen in SD rats. Myofibroblasts in the portal tracts were more abundant along with the increased amount of loose connective tissue in PCK rats compared to SD rats ( Fig. 1D and Fig. 3B ). Interestingly, in 3W and adult PCK rats, there were no or few myofibroblasts around C-type bile ducts, similar to SD rats, although myofibroblasts were still present around F-type bile ducts (Fig. 2B) .
Quantitative analysis of a-SMA-positive areas in the livers showed that the percentage of a-SMA-positive areas increased slightly until 1D and decreased thereafter in SD rats (Fig. 3C) . In PCK rats, the percentage of a-SMA-positive areas peaked (5.51 6 2.41%) in 1W, being 2.7 times higher than in 1W SD rats (2.00 6 0.97%) (P , 0.05). Later, a-SMA-positive areas decreased and there were no differences between 3W PCK and SD rats (1.27 6 0.67% and 0.98 6 0.52%, respectively).
Immunohistochemistry: expression of Notch family-related factors
Jagged1, Jagged2, and Notch1 Jagged1 was expressed in the cytoplasm of mesenchymal cells of the portal tracts, particularly around the bile ducts and portal vasculature, including portal veins and hepatic arteries in E20D and 1D SD and PCK rats and in periportal areas and focally around the portal vasculature in 1W SD and PCK rats (Fig. 4A,B) . Double immunostaining showed that a majority of Jagged1-positive cells were also positive for a-SMA. Jagged1-positive mesenchymal cells in portal tracts of E20D, 1D, and 1W PCK rats outnumbered those of SD rats. In 3W SD and PCK rats, Jagged1 was not expressed in mesenchymal cells in the portal tracts, except for its expression on scattered mesenchymal cells around C-type bile ducts.
Jagged2 and Notch1 were also expressed in the cytoplasm of mesenchymal cells scattered in the portal tracts, particularly around the portal veins in E20D, 1D, and 1W PCK and SD rats ( Fig. 5 A,B) . Double immunostaining showed that all Jagged2-and Notch1positive cells were also positive for a-SMA. Jagged2-and Notch 1-positive mesenchymal cells were not found in the portal tracts of either strain of 3W rats, except on a few mesenchymal cells around F-type bile ducts. In SD rats, a-SMA-positive mesenchymal cells (myofibroblasts) were found in the portal tracts, particularly around the bile ducts and portal veins, in 20 embryonic-day-old (E20D), 1-day-old (1D), and 1-week-old (1W) rats. In 3W rats, vascular smooth muscles remained present, although the expression of a-SMA in mesenchymal cells in portal tracts, including
Notch2
Notch2 was diffusely expressed in the cytoplasm of hepatocytes and cholangiocytes of both rats, and its expression was rather weak in the hepatocytes (Fig. 6A,B) . The expression of cytoplasmic Notch2 was similar in cholangiocytes in E20D, 1D, 1W, and 3W SD and PCK rats. It was also similarly positive in cholangiocytes of Fand C-type bile ducts of PCK rats. It was focally expressed in mesenchymal cells of the portal tracts.
Hes1
Hes1 was expressed in the nuclei of cholangiocytes of the bile ducts throughout the developmental stages examined, and its expression was slightly stronger in PCK rats compared to SD rats. It was expressed similarly in F-and C-type bile ducts of PCK rats (Table 3) .
RT-PCR: mRNA level of Notch family-related factors
The timecourse of mRNA expression of Notch1, Notch2, Jagged1, Jagged2, and Hes1 in liver specimens of both rats is shown in Figure 7 . In E18D, E20D, 1D, 1W, and 3W rats, the mRNA level of Notch1 in PCK rats was similar to that in SD rats. Meanwhile, the level of mRNA of Notch2, Jagged1, and Jagged2 was similar in E18D and E20D PCK and SD rats but tended to be higher in 1D and 1W PCK rats.
Expression of Hedgehog family-related factors
Immunohistochemical expression of Shh
Shh was weakly expressed in the cytoplasm of cholangiocytes in PCK and SD rats ( Figure 8A,B) . It was expressed similarly in cholangiocytes of F-and C-type bile ducts of PCK rats.
mRNA level of Shh
Reverse transcription polymerase chain reaction showed that the expression of Shh mRNA was very low or undetectable in E18D, E20D, and D1 PCK and SD rats but increased in 3W PCK and SD rats, with no statistically significant difference between the 2 strains ( Fig. 8C ).
Expression of Ki67 and ssDNA
The Ki67 and ssDNA LIs of cholangiocytes of the bile ducts are shown in Figure 9 . Although the Ki-67 LI was 6.1 6 7.2%, 7.4 6 4.4%, and 9.5 6 5.7% in 1D, 1W, and 3W SD rats, respectively, it was significantly higher in PCK rats (8.9 6 3.9%, 15.3 6 5.6%, and 17.7 6 4.3%, respectively). In contrast, the ssDNA LI was lower, and there was no difference in 1D, 1W, and 3W PCK and SD rats.
DISCUSSION
Alpha smooth muscle antigen-positive mesenchymal cells (myofibroblasts) were diffusely distributed in portal tracts of both rat strains and abundant in PCK rats. Interestingly, such cells almost disappeared in 3W SD and PCK rats, except around the F-type bile ducts of PCK rats. Jagged1 was expressed in myofibroblasts in portal tracts, particularly around the bile ducts and portal vasculature in E20D and 1D rats and in periportal areas in 1W rats, and Jagged1-positive myofibroblasts were rather abundant in PCK rats. Notch2 was expressed in the cholangiocytes in both strains. Shh was similarly expressed in the cholangiocytes of bile ducts in both rats. All the Notch and Hh signaling pathway molecules examined were expressed in myofibroblasts and/or cholangiocytes of both rats. A well-balanced expression of Notch and Hh-related molecules in portal tracts is important for the normal development of IHBD in SD rats, and an imbalanced expression of Jagged1 in periductal and periportal myofibroblasts and interaction with Notch2 on the cholangiocytes may be involved in the formation of bile duct lesions in PCK rats.
Previous studies suggested that cells or factors in the portal areas contributed to the differentiation of hepatoblasts into cholangiocytes and formation of bile ducts [21] . Intrahepatic bile ducts are formed along with the portal veins consisting of endothelial cells and mesenchymal cells, and at the later embryonic stage, the interaction of myofibroblasts and cholangiocytes reportedly contributes to the formation of IHBD in mice [14] . It was found in this study that the myofibroblasts were distributed in the portal tracts in E20D, 1D, and 1W SD rats, suggesting that the interaction of portal myofibroblasts and cholangiocytes at this stage is important in the normal development of IHBD. There are several reports that Jagged1-positive mesenchymal cells located in the portal area, particularly in the periportal area where ductal plates and bile ducts are formed and remodeled, were important for the development of IHBD [14] . Jagged1positive portal vein mesenchymal cells instruct hepatoblasts expressing Notch2, a receptor of Jagged1, to become cholanigocytes and hence induce the differentiation of hepatoblasts into cholangiocytes [14, 22] . The signaling pathway of Notch2 in cholangiocytes promotes fate r periductal areas, disappeared. In E18D, E20D, 1D, and 1W PCK rats, the distribution of a-SMA expression was similar to that in SD rats. However, a-SMA-positive regions were abundant compared to those in SD rats. In addition, flat-shaped bile ducts (arrow) in 3W PCK rats were still surrounded by a-SMA-positive cells. Bar 5 100 mm. C. Comparison of a-SMA-positive areas in the liver specimens between SD and PCK rats (percentage of positive areas) according to age showed that a-SMApositive areas of PCK rats ( N ) were more abundant than those in SD rats (#). The percentage peaked significantly in 1W PCK rats. (P , 0.05) . The data are shown as the mean of 5 separate measurements, and the error bars show standard deviations. . Double immunofluorescence staining for Jagged1 (green) and a-smooth muscle actin (a-SMA) (red) in 1-day-old (1D) and 1-week old (1W) Sprague Dawley (SD) (A) and polycystic kidney (PCK) (B) rats. A. Expression of Jagged1 was found in mesenchymal cells of the portal tracts, particularly around portal veins and also bile ducts in 1D SD rats and in periportal areas and focally around bile ducts and blood vessels in 1W SD rats. A majority of Jagged1-positive cells were also positive for a-SMA. B. Jagged1 was expressed in mesenchymal cells of the portal tracts, particularly around blood vessels and also bile ducts in 1D PCK rats and in periportal areas and focally around blood vessels in 1W PCK rats. A majority of Jagged1positive cells were also positive for a-SMA. The number of Jagged1-positive cells and a-SMA-positive cells of PCK rats outnumbered that of SD rats. BD, bile duct; PV, portal vein. Nuclear staining was performed with DAPI (in blue). specification of bile ducts and tubulogenesis in mice [23] [24] [25] . A hallmark of Notch signaling pathways is the requirement of direct cell-to-cell contact, because both Notch ligands and receptors are integral membrane proteins [26] ). Thus, IHBD development in the late embryonic stage is dependent on Jagged1 and Notch2 expressed in portal tracts [14, [16] [17] [18] . This study also showed that Jagged1 was expressed in periductal and periportal myofibroblasts and Notch2 was expressed in cholangiocytes of E20D, 1D, and 1W SD rats, which supports the idea that a well-balanced and time sequential expression of Jagged1 and Notch2 in the portal tracts and their interaction are essential in the development of IHBD.
Impaired signaling pathways of the Notch family, particularly Notch2 and Jagged1, may therefore be involved in the development of anomalous IHBD [16] [17] [18] . For example, loss of Jagged1 expression in the periductal mesenchyma due to mutations of Jagged1 leads to AGA with defective bile duct development beyond the initial formation of the ductal plate [19] . In contrast, activation of the Notch pathway by forced expression of the Notch intracellular domain in hepatoblasts enhanced cholangiocyte differentiation but suppressed hepatocyte differentiation [14, 22] . The sustained expression of the intracellular domain of Notch2 (Notch 2ICD) led to additional bile ducts in periportal regions and ectopic ducts in lobular regions, and the additional bile ducts in periportal regions were maintained into adulthood, resulting in an increased number of bile ducts per portal tract [15] .
Polycystic kidney rats are known to show DPM (failure of remodeling of bile ducts), and several pathogenetic mechanisms, such as altered cell kinetics, have been proposed to explain this appearance [2] [3] [4] 11, 20] . However, there have been no studies on the roles of Notch and Hh expression and signaling pathways in cholangiocytes and mesenchymal cells in the livers of PCK rats. It was found in this study that myofibroblasts were abundant in E20D, 1D, and 1W PCK rats compared to SD rats, and this abundance was also confirmed by semiquantitative evaluation of a-SMA immunostaining. This study showed that the Notch family members examined were expressed in the liver of PCK rats as seen in control rats. However, the number of Jagged1positive myofibroblasts was apparently increased around the bile ducts and portal vasculature and also in the periportal area of PCK rats. Thus, the cholangiocytes of bile ducts of PCK rats at this stage were speculated to be exposed to increased and continuous Jagged1 expression from myofibroblasts. Notch2 expressed in cholangiocytes of bile ducts may interact with Jagged1, suggesting that the myofibroblast-mediated continuous and enhanced activation of Notch2-Jagged1 interaction in cholangiocytes might contribute to the bile duct lesions of PCK rats. Reverse transcription polymerase chain reaction also showed that the mRNA expression of Notch2 and Jagged1 was upregulated in PCK rats after birth, supporting the above-mentioned suggestion. The finding that the Ki-67 LI was high in the cholangiocytes of PCK rats suggested that increased proliferation of cholangiocytes due to the activation of the Notch2/Jagged1 signaling pathway might have contributed to the formation of DPM [2] . Taken together, imbalanced interaction of Jagged1 from myofibroblasts with Notch2 in cholangiocytes may be involved in the formation of bile duct lesions in PCK rats. In contrast, Jagged2 was mainly expressed in myofibroblasts around the portal veins, suggesting that Jagged2 was not involved directly in the bile duct lesions of PCK rats at this developmental stage. Hes1, a downstream target of Notch signaling pathways and regulator of bile duct morphogenesis [23, 24] , was expressed in the nuclei of cholangiocytes of IHBD in E20D, 1D, and 1W SD and PCK rats; its expression on cholangiocytes was slightly stronger and its mRNA level was increased in PCK compared to SD rats. Interaction of Notch2 in cholangiocytes with Jagged1positive myofibroblasts may activate Hes1 in cholangiocytes, possibly involved in the formation of DPM. Meckel syndrome (MKS) is an another rare autosomal recessive disease with DPM and polycystic kidneys [19, 20] . The gene mutated in type 1 MKS (Mks1) encodes a protein associated with the cilium in vertebrates, and loss of function of mouse Mks1 is an animal model of human MKS with DPM. This bile duct alteration is likely to be the result of the disruption of the Hh signaling pathway. However, the present study showed that Shh was similarly expressed in bile ducts and the mRNA level of Shh was similar in the livers of both rats, suggesting that disruption of the Shh signaling pathway was unlikely involved in the formation of DPM in PCK rats.
Liu and colleagues [25] reported that in the lung and kidney, Notch1 after interaction with its ligand, Jagged1, caused the activation of myofibroblasts. Notch1-Jagged1 interaction may also contribute to the enlargement of mesenchymal cells in the portal area during the formation of bile ducts [17] . It was found in this study that like Jagged1, Notch1 was expressed in mesenchymal cells in the portal tracts, particularly around the bile ducts and portal veins, in PCK and SD rats and that numbers of Notch1-positive myofibroblasts were increased, as seen for Jagged1 in PCK rats compared to SD rats, suggesting that mutual interaction of Jagged1 and Notch1 in myofibroblasts might have resulted in an increased number of myofibroblasts themselves around bile ducts.
As for the 2 types of bile ducts in PCK rats [11] , there were no a-SMA-positive myofibroblasts around C-type bile ducts, but F-type bile ducts remained surrounded by ( N ) rats. There was no difference in the mRNA level of Notch1 between 18 embryonic-day-old (E18D), E20D, 1-day-old (1D), 1-week-old (1W), and 3W PCK and SD rats. Meanwhile, although the levels of mRNA for Notch2, Jagged1, and Jagged2 were similar in E18D and E20D PCK and SD rats, they tended to be slightly higher in the 1D and/or 1W PCK rats. *, P , 0.05. myofibroblasts expressing Jagged1 and Notch1. According to our previous study [11] , F-type bile ducts showed reduced immunohistochemical expression of the biliary epithelial marker CK-19 and aberrant immunoreactivity for vimentin and fibronectin. In mouse cholangiocytes cocultured with myofibroblastic hepatic stellate cells, Hh ligands from these stellate cells promoted epithelial mesenchymal transition (EMT) of cholangiocytes. The activation of Hh signaling pathways induces immature cholangiocytes to express mesenchymal markers in the bile ducts and also to undergo EMT, which is likely to contribute to bile duct lesions and fibrosis [26] . It was found in this study that Shh was expressed in the cholangiocytes of the F-and C-type bile ducts in PCK rats. Shh expressed in F-type bile ducts may be involved in the EMT of these cholangiocytes, suggesting Hh signaling pathways to be at least partly involved in the EMT of F-type bile ducts of PCK rats.
In conclusion, the results obtained here suggest that all members of the Notch and Hh families examined were expressed in portal tracts and bile ducts of both PCK and SD rats and that the number of Jagged1-positive myofibroblasts was increased around the bile ducts of PCK rats. A relatively increased level of Jagged1 expression in myofibroblasts along with Notch2 expression in cholangiocytes may be involved in the formation of DPM in PCK rats. More studies are needed to test whether these molecules related to Notch signaling pathways could be a target in the treatment of Caroli's disease. 
